What question did this study set out to answer?

The aim is to evaluate the efficacy of a small molecule activator of PP2A in treating group 3 medulloblastoma and its associated metastasis.

March 25, 2026Cancer Research

Abstract B059: A small molecule activator of the tumor suppressor phosphatase PP2A overcomes leptomeningeal dissemination in group 3 medulloblastoma

View Full Paper

Ask AI

Bookmark

Authors

NNNazia Nazam MEMichael H Erwin JJJ R JulsonUniversity of Alabama at Birmingham

Discussion

Member takes

Implication

Novel small molecule activator targets PP2A to reduce leptomeningeal metastasis in group 3 medulloblastoma, suggesting a new treatment option for pediatric patients.

Key Points

The aim is to evaluate the efficacy of a small molecule activator of PP2A in treating group 3 medulloblastoma and its associated metastasis.
In vitro experiments assessing the effects of (-)-ATUX-1215 on PP2A activation and dephosphorylation of targets in cancer cells.
Use of a patient-derived xenograft (PDX) mouse model to test the impact of ATUX-1215 on leptomeningeal dissemination.
Evaluation of safety, drug metabolism, and pharmacokinetics of ATUX-1215.
(-)-ATUX-1215 effectively activates PP2A, leading to decreased pERK and pAKT levels.
Significant suppression of leptomeningeal dissemination observed in the PDX mouse model.
ATUX-1215 showed synergistic effects with CHK1 kinase inhibition.
Potential reduction of pro-metastatic effects associated with radiation by inhibiting CCL2/CCR2 expression via NF-kB.

Cite This Study

Nazam et al. (2026) studied this question.

synapsesocial.com/papers/69c37afeb34aaaeb1a67cff9 https://doi.org/10.1158/1538-7445.brain26-b059

View Full Paper

Ask AI

Bookmark

Implication

Novel small molecule activator targets PP2A to reduce leptomeningeal metastasis in group 3 medulloblastoma, suggesting a new treatment option for pediatric patients.

Abstract B059: A small molecule activator of the tumor suppressor phosphatase PP2A overcomes leptomeningeal dissemination in group 3 medulloblastoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Abstract B059: A small molecule activator of the tumor suppressor phosphatase PP2A overcomes leptomeningeal dissemination in group 3 medulloblastoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider